Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.
Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effect Marks final study needed for the upcoming FDA meeting for...
GLEN ALLEN, Va., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
GLEN ALLEN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.09 | -8.10810810811 | 1.11 | 1.28 | 0.9924 | 511703 | 1.10840902 | CS |
4 | -0.08 | -7.27272727273 | 1.1 | 1.28 | 0.9696 | 196223 | 1.0836954 | CS |
12 | 0.05 | 5.15463917526 | 0.97 | 1.28 | 0.9355 | 143290 | 1.06097355 | CS |
26 | -0.46 | -31.0810810811 | 1.48 | 3 | 0.9 | 1455681 | 1.28224587 | CS |
52 | -1.1 | -51.8867924528 | 2.12 | 4.12 | 0.765 | 2325931 | 1.96885023 | CS |
156 | -73.98 | -98.64 | 75 | 78.5 | 0.765 | 1157442 | 6.24334639 | CS |
260 | -38.98 | -97.45 | 40 | 127 | 0.765 | 1010820 | 24.3864689 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約